EUVIMEDEUVIMED entdecken
Crossref

FRET-based mesoporous organosilica nanoplatforms for in vitro and in vivo anticancer two-photon photodynamic therapy

Nicolas Bondon iD, Clément Charlot, Lamiaa M A Ali, Alexandre Barras, Nicolas Richy, Denis Durand, Yann Molard iD, Grégory Taupier, Erwan Oliviero iD, Magali Gary-Bobo iD, Frédéric Paul iD, Sabine Szunerits iD und 6 weitere

Journal of Materials Chemistry B · 2025

DOI: 10.1039/d4tb02103g ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2025. Verfasst von Nicolas Bondon und 17 weiteren Autor:innen. Beteiligte Einrichtung: ICGM, University of Montpellier, UMR-CNRS 5253, 34293 Montpellier, France. nicolas.bondon@concordia.ca. Hauptthemen laut MEDLINE: Photochemotherapy, Organosilicon Compounds, Nanoparticles, Fluorescence Resonance Energy Transfer. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Design of multifunctional photoactive periodic mesoporous organosilica nanoparticles integrating chromphores for FRET-based two photon excitation fluorescence and photodynamic therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyOrganosilicon CompoundsNanoparticlesFluorescence Resonance Energy TransferAntineoplastic AgentsPhotosensitizing AgentsHumansAnimalsZebrafishPhotonsPorosityDrug Screening Assays, AntitumorCell SurvivalParticle SizeSurface PropertiesCell Line, Tumor

Substanzen

Organosilicon CompoundsAntineoplastic AgentsPhotosensitizing Agents

Autor:innen und Institutionen

  • ICGM, University of Montpellier, UMR-CNRS 5253, 34293 Montpellier, France. nicolas.bondon@concordia.ca.
  • Univ Rennes, CNRS, ISCR (Institut des Sciences Chimiques de Rennes) - UMR 6226, ScanMAT - UAR 2025, F-35000, Rennes, France. olivier.mongin@univ-rennes1.fr.
  • IBMM, University of Montpellier, UMR-CNRS 5247, 34293 Montpellier, France.
  • Department of Biochemistry, Medical Research Institute, Alexandria University, Alexandria, 21561, Egypt.
  • Univ. Lille, CNRS, Univ. Polytechnique Hauts-de-France, UMR 8520-IEMN, 59000 Lille, France.

ORCID-Profile: Nicolas Bondon, Yann Molard, Erwan Oliviero, Magali Gary-Bobo, Frédéric Paul, Sabine Szunerits, Nadir Bettache, Jean-Olivier Durand, Olivier Mongin, Clarence Charnay

Förderung

  • Agence Nationale de la Recherche

Zitieren

APA

Bondon, N., Charlot, C., Ali, L. M. A., Barras, A., Richy, N., Durand, D., Molard, Y., Taupier, G., Oliviero, E., Gary-Bobo, M., Paul, F., Szunerits, S., Bettache, N., Durand, J. O., Nguyen, C., Boukherroub, R., Mongin, O., & Charnay, C. (2025). FRET-based mesoporous organosilica nanoplatforms for in vitro and in vivo anticancer two-photon photodynamic therapy. Journal of Materials Chemistry B. https://doi.org/10.1039/d4tb02103g

Vancouver

Bondon N, Charlot C, Ali LMA, Barras A, Richy N, Durand D, et al. FRET-based mesoporous organosilica nanoplatforms for in vitro and in vivo anticancer two-photon photodynamic therapy. Journal of Materials Chemistry B. 2025. doi:10.1039/d4tb02103g

BibTeX
@article{Bondon2025,
  author = {Bondon, Nicolas and Charlot, Clément and Ali, Lamiaa M A and Barras, Alexandre and Richy, Nicolas and Durand, Denis and Molard, Yann and Taupier, Grégory and Oliviero, Erwan and Gary-Bobo, Magali and Paul, Frédéric and Szunerits, Sabine and Bettache, Nadir and Durand, Jean-Olivier and Nguyen, Christophe and Boukherroub, Rabah and Mongin, Olivier and Charnay, Clarence},
  title = {FRET-based mesoporous organosilica nanoplatforms for in vitro and in vivo anticancer two-photon photodynamic therapy},
  journal = {Journal of Materials Chemistry B},
  year = {2025},
  doi = {10.1039/d4tb02103g}
}
Kostenlos starten →